RXST

RxSight, Inc. (RXST)

NASDAQ
$7.81
$-0.19
(-2.37%)
RxSight, Inc. (RXST) Live Price Chart
Page last updated: 2026-02-12 20:21:00

Key Market Data

$320.92M

$8.19

$66.54

$6.32

$8.03

$-0.19

-2.37%

564K

RxSight, Inc. (RXST) Stock Price Today

RxSight, Inc. (RXST) is currently trading at $7.81 as of 2026-02-12 20:21:00, reflecting a -2.37% move ($-0.19) from the previous close.

In the short term, the stock has returned -1,928.65% over the past four weeks. Over the last 12 months, RxSight, Inc. has recorded a -75.53% price change, indicating a weak performance relative to the broader market.

RxSight, Inc. (RXST) 7-Day Stock Price Changes

Over the past seven days, RxSight, Inc. has traded within a short-term range shaped by market sentiment in the OPHTHALMIC GOODS sector. During this period, the stock moved from its previous closing price of $7.94 to the latest recorded price of $7.81, reflecting an intraday change of -2.37%. Daily movements highlight shifts in trading volume (563,741), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, RXST has delivered a -1,928.65% return over the past month and a -75.53% change in the last 12 months, indicating a weak trend relative to its broader sector peers.

How to Buy RxSight, Inc. (RXST)

You can buy and trade RXST on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account
Step 1: Create and Verify Your MEXC Account
Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.
Step 2: Deposit Funds Into Your Account
Step 2: Deposit Funds Into Your Account
Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.
Step 3: Search for RXST and Execute Your Trade
Step 3: Search for RXST and Execute Your Trade
Open the trading page, enter RXST in the search bar, select the amount of RXST you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is RxSight, Inc. (RXST)?

RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.

RxSight, Inc. Information

Industry
OPHTHALMIC GOODS
Employees
498
Sector
OPHTHALMIC GOODS
Company Website

Frequently Asked Questions (FAQ)

1.What is the current share price of RxSight, Inc.?
The latest trading price for RxSight, Inc. (Common Stock) is $ 7.81, compared with a previous closing price of $ 8.03. That means the stock has moved -2.37% so far today. Intraday price updates and recent trading activity for RXST can be tracked on the live chart and quote section on this page.
2.Is RxSight, Inc. stock going up or down?
Looking at recent performances, RXST has returned -1,928.65% over the past month, -8.07% over the last six months and -75.53% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe weak price momentum for RxSight, Inc. stock, but keep in mind that past returns do not guarantee future results.
3.Where does RXST currently sit relative to its 52-week high and low?
In the most recent 52-week period, RxSight, Inc. has traded between a low of $ 6.32 and a high of $ 32.25. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether RXST is currently nearer the top or the bottom of its one-year trading band.
4.How is RxSight, Inc. classified by sector and industry?
RxSight, Inc. is classified in the OPHTHALMIC GOODS sector. In practice, this means RxSight, Inc. is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing RXST’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the OPHTHALMIC GOODS sector could influence RxSight, Inc.’s performance.
5.Where is RxSight, Inc. listed and how large is it by market value?
RxSight, Inc. is listed on the NASDAQ stock exchange in United States. Based on a market capitalization of $ 320.92M, the company is classified as a Small-cap stock. Market cap gives a quick sense of RxSight, Inc.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.
6.What does RXST's EPS tell investors about its profitability?
Trailing-twelve-month EPS of $ -0.87 summarises how much profit RxSight, Inc. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.
7.How can I track RxSight, Inc.'s financial performance over time?
To follow RxSight, Inc.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how RXST is performing and how the market is responding.
8.When is RxSight, Inc. expected to report earnings?
RxSight, Inc.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for RXST, as they provide updated information on revenue, profitability and management's outlook.
9.What usually comes out in RxSight, Inc.'s earnings reports?
RxSight, Inc.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether RXST is meeting, beating or missing expectations.
10.How can I stay informed about RxSight, Inc.'s results and guidance?
You can stay up to date on RxSight, Inc. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for RXST on this page helps you see how new information is being reflected in the stock.
11.Does RxSight, Inc. pay a regular cash dividend to its shareholders?
RxSight, Inc. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor RXST's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.
12.What are the current dividend yield and dividend payout ratio for RXST?
Based on the latest earnings data, RXST has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether RxSight, Inc. is an attractive income stock. The dividend payout ratio measures what percentage of earnings RxSight, Inc. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.
13.What kind of business is RxSight, Inc.?
RxSight, Inc. is a publicly traded company in the OPHTHALMIC GOODS industry within the OPHTHALMIC GOODS sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.
14.How is RXST valued in terms of P/E ratio and EPS?
RxSight, Inc. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of $ -0.87. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of RxSight, Inc.'s earnings. Comparing RXST's P/E and EPS to those of other OPHTHALMIC GOODS companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as RxSight, Inc.

Largest Market Cap

See US stocks with the highest market capitalization

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

RXST-to-USD Calculator

Amount

RXST
RXST
USD
USD

1 RXST = 7.805 USD